To further isolate the contributions of tumor cell TPr and platelet TPr to the antimetastatic efficacy of ifetroban, we conducted additional studies in an experimental hematogenous model of metastasis lacking a primary tumor and using TBXA2R-deleted tumor cells. The gene discussed is TBXA2R; the disease is neoplasm.